Purchases and Sales Made in Q4 2022 in Aerovate Therapeutics, Inc. (AVTE)
This table provides information about the institutional ownership of Aerovate Therapeutics, Inc. (AVTE) during Q4 2022. The information is specifically focused on institutions that hold shares of Aerovate Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2.57K- 54.03% |
$41K - $78.6K
|
2.19K
$5.76K
|
|
|
Feb 14, 2023
Q4 2022
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-2.7K- 0.14% |
$43K - $82.4K
|
1.98M
$5.2M
|
|
|
Feb 08, 2023
Q4 2022
|
Skandinaviska Enskilda Banken Ab (Publ)
Stockholm, V7 |
SELL
|
- |
-3.09K- 5.48% |
$49.2K - $94.3K
|
53.3K
$140K
|
|
|
Feb 14, 2023
Q4 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-4.8K- 14.0% |
$76.4K - $147K
|
29.5K
$77.6K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-5.17K- 40.63% |
$82.3K - $158K
|
7.56K
$19.9K
|
|
|
Feb 14, 2023
Q4 2022
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-9.94K- 27.81% |
$158K - $303K
|
25.8K
$67.9K
|
|
|
Feb 14, 2023
Q4 2022
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-15K- 10.0% |
$239K - $458K
|
135K
$355K
|
|
|
Feb 14, 2023
Q4 2022
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-34.3K- 18.83% |
$546K - $1.05M
|
148K
$389K
|
|
|
Feb 14, 2023
Q4 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-35.5K- 4.46% |
$565K - $1.08M
|
760K
$2M
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-53.7K- 3.32% |
$854K - $1.64M
|
1.56M
$4.11M
|
|
|
Feb 14, 2023
Q4 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-72.1K- 36.04% |
$1.15M - $2.2M
|
128K
$336K
|
|
|
Feb 14, 2023
Q4 2022
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-86.1K- 10.32% |
$1.37M - $2.63M
|
748K
$1.97M
|
|
|
May 15, 2023
Q4 2022
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-86.1K- 10.32% |
$1.37M - $2.63M
|
748K
$1.97M
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-107K- 15.02% |
$1.71M - $3.28M
|
608K
$1.6M
|
|
|
Feb 14, 2023
Q4 2022
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-310K- 13.33% |
$4.94M - $9.47M
|
2.02M
$5.31M
|
|
|
Feb 14, 2023
Q4 2022
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-374K- 16.03% |
$5.95M - $11.4M
|
1.96M
$5.15M
|